Q: Why is it necessary for coders, CDI professionals, and providers to align documentation and coding for substance-related disorders when applying both the DSM-5 and ICD-10? How does this impact risk adjustment and HCC capture?Read More »
Q: What are Elixhauser comorbidities, and how does present on admission (POA) status, clinical significance, and sequencing play a role in reporting them?Read More »
Q: We struggle with the use of the clinical validation query type. Would others be able to share their best practices for this type of query? Read More »
Q: In the 2026 ICD-10-CM update, in the neoplasm chapter there are some added specific codes for inflammatory neoplasm of the breast. How do those differ from other types of breast cancer?Read More »
As part of the fifteenth annual Clinical Documentation Integrity Week, which took place last week (September 15-19, 2025), ACDIS conducted a series of interviews with CDI professionals on a variety of emerging industry topics. Debbie Breton, BSN, RN, CCDS, a CDI educator at...Read More »
